Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA: Cancer J Clin 2011; 61:69-90; PMID:21296855
   PubMed Web of Science ®Google Scholar
• Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 2005; 241:27-39; PMID:15621988
   PubMed Web of Science ®Google Scholar
• Roth AD. Curative treatment of gastric cancer: towards a multidisciplinary approach? Crit Rev Oncol Hematol 2003; 46:59-100; PMID:12672518; http://dx.doi.org/10.1016/S1040-8428(02)00160-9
   PubMed Web of Science ®Google Scholar
• Krejs GJ. Gastric cancer: epidemiology and risk factors. Digest Dis 2010; 28:600-3; PMID:21088409; http://dx.doi.org/10.1159/000320277
   PubMed Web of Science ®Google Scholar
• Zhang J, Yang PL, Gray NS. Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 2009; 9:28-39; PMID:19104514; http://dx.doi.org/10.1038/nrc2559
   PubMed Web of Science ®Google Scholar
• Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, Lydon NB. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996; 2:561-6; PMID:8616716; http://dx.doi.org/10.1038/nm0596-561
   PubMed Web of Science ®Google Scholar
• Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 2001; 344:1038-42; PMID:11287973; http://dx.doi.org/10.1056/NEJM200104053441402
   PubMed Web of Science ®Google Scholar
• Shepherd FA, Rodrigues Pereira J, Ciuleanu T, Tan EH, Hirsh V, Thongprasert S, Campos D, Maoleekoonpiroj S, Smylie M, Martins R, et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005; 353:123-32; PMID:16014882; http://dx.doi.org/10.1056/NEJMoa050753
   PubMed Web of Science ®Google Scholar
• Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001; 344:783-92; PMID:11248153; http://dx.doi.org/10.1056/NEJM200103153441101
   PubMed Web of Science ®Google Scholar
• Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010; 376:687-97; PMID:20728210; http://dx.doi.org/10.1016/S0140-6736(10)61121-X
   PubMed Web of Science ®Google Scholar
• Sheng WQ, Huang D, Ying JM, Lu N, Wu HM, Liu YH, Liu JP, Bu H, Zhou XY, Du X. HER2 status in gastric cancers: a retrospective analysis from four Chinese representative clinical centers and assessment of its prognostic significance. Ann Oncol 2013; 24:2360-4; PMID:23788757; http://dx.doi.org/10.1093/annonc/mdt232
   PubMed Web of Science ®Google Scholar
• Smolen GA, Sordella R, Muir B, Mohapatra G, Barmettler A, Archibald H, Kim WJ, Okimoto RA, Bell DW, Sgroi DC, et al. Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752. Proc Natl Acad Sci U S A 2006; 103:2316-21; PMID:16461907; http://dx.doi.org/10.1073/pnas.0508776103
   PubMed Web of Science ®Google Scholar
• Deng N, Goh LK, Wang H, Das K, Tao J, Tan IB, Zhang S, Lee M, Wu J, Lim KH, et al. A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets. Gut 2012; 61:673-84; PMID:22315472; http://dx.doi.org/10.1136/gutjnl-2011-301839
   PubMed Web of Science ®Google Scholar
• Sutton CW, Rustogi N, Gurkan C, Scally A, Loizidou MA, Hadjisavvas A, Kyriacou K. Quantitative proteomic profiling of matched normal and tumor breast tissues. J Proteome Res 2010; 9:3891-902; PMID:20560667; http://dx.doi.org/10.1021/pr100113a
   PubMed Web of Science ®Google Scholar
• Chaerkady R, Harsha HC, Nalli A, Gucek M, Vivekanandan P, Akhtar J, Cole RN, Simmers J, Schulick RD, Singh S, et al. A quantitative proteomic approach for identification of potential biomarkers in hepatocellular carcinoma. J Proteome Res 2008; 7:4289-98; PMID:18715028; http://dx.doi.org/10.1021/pr800197z
   PubMed Web of Science ®Google Scholar
• Chen JS, Chen KT, Fan CW, Han CL, Chen YJ, Yu JS, Chang YS, Chien CW, Wu CP, Hung RP. Comparison of membrane fraction proteomic profiles of normal and cancerous human colorectal tissues with gel-assisted digestion and iTRAQ labeling mass spectrometry. FEBS J 2010; 277:3028-38; PMID:20546304; http://dx.doi.org/10.1111/j.1742-4658.2010.07712.x
   PubMed Web of Science ®Google Scholar
• Gagné J-P, Éthier C, Gagné P, Mercier G, Bonicalzi M-È, Mes-Masson A-M, Droit A, Winstall E, Isabelle M, Poirier GG. Comparative proteome analysis of human epithelial ovarian cancer. Proteome Sci 2007; 5:16; PMID:17892554
   PubMed Web of Science ®Google Scholar
• Mathivanan S, Ahmed M, Ahn NG, Alexandre H, Amanchy R, Andrews PC, Bader JS, Balgley BM, Bantscheff M, Bennett KL, et al. Human Proteinpedia enables sharing of human protein data. Nat Biotechnol 2008; 26:164-7; PMID:18259167; http://dx.doi.org/10.1038/nbt0208-164
   PubMed Web of Science ®Google Scholar
• Pawar H, Kashyap MK, Sahasrabuddhe NA, Renuse S, Harsha HC, Kumar P, Sharma J, Kandasamy K, Marimuthu A, Nair B, et al. Quantitative tissue proteomics of esophageal squamous cell carcinoma for novel biomarker discovery. Cancer Biol Ther 2011; 12:510-22; PMID:21743296; http://dx.doi.org/10.4161/cbt.12.6.16833
   PubMed Web of Science ®Google Scholar
• Zhang L, Jiang J, Arellano M, Zhang L, Yan X, Wong DT, Hu S. Quantification of serum proteins of metastatic oral cancer patients using LC-MS/MS and iTRAQ labeling. Open Proteomics J 2008; 1:72; PMID:20485468; http://dx.doi.org/10.2174/1875039700801010072
   PubMedGoogle Scholar
• Chong PK, Lee H, Loh MC, Choong LY, Lin Q, So JB, Lim KH, Soo RA, Yong WP, Chan SP, et al. Upregulation of plasma C9 protein in gastric cancer patients. Proteomics 2010; 10:3210-21; PMID:20707004; http://dx.doi.org/10.1002/pmic.201000127
   PubMed Web of Science ®Google Scholar
• Deng L, Su T, Leng A, Zhang X, Xu M, Yan L, Gu H, Zhang G. Upregulation of soluble resistance-related calcium-binding protein (sorcin) in gastric cancer. Med Oncol 2010; 27:1102-8; PMID:19885748; http://dx.doi.org/10.1007/s12032-009-9342-5
   PubMed Web of Science ®Google Scholar
• Loei H, Tan HT, Lim TK, Lim KH, So JB-Y, Yeoh KG, Chung MC. Mining the gastric cancer secretome: identification of GRN as a potential diagnostic marker for early gastric cancer. J Proteome Res 2012; 11:1759-72; PMID:22204653; http://dx.doi.org/10.1021/pr201014h
   PubMed Web of Science ®Google Scholar
• Marimuthu A, Subbannayya Y, Sahasrabuddhe NA, Balakrishnan L, Syed N, Sekhar NR, Katte TV, Pinto SM, Srikanth SM, Kumar P, et al. SILAC-based quantitative proteomic analysis of gastric cancer secretome. Proteomics Clin Appl 2013; 7:355-66; PMID:23161554; http://dx.doi.org/10.1002/prca.201200069
   PubMed Web of Science ®Google Scholar
• Yang Y, Lim SK, Choong LY, Lee H, Chen Y, Chong PK, Ashktorab H, Wang TT, Salto-Tellez M, Yeoh KG, et al. Cathepsin S mediates gastric cancer cell migration and invasion via a putative network of metastasis-associated proteins. J Proteome Res 2010; 9:4767-78; PMID:20812763; http://dx.doi.org/10.1021/pr100492x
   PubMed Web of Science ®Google Scholar
• Monteith GR, McAndrew D, Faddy HM, Roberts-Thomson SJ. Calcium and cancer: targeting Ca2+ transport. Nat Rev Cancer 2007; 7:519-30; PMID:17585332; http://dx.doi.org/10.1038/nrc2171
   PubMed Web of Science ®Google Scholar
• Monteith GR, Davis FM, Roberts-Thomson SJ. Calcium channels and pumps in cancer: changes and consequences. J Biol Chem 2012; 287:31666-73. PMID: 22822055
   Google Scholar
• Berridge MJ. Calcium signalling and cell proliferation. Bioessays 1995; 17:491-500; PMID:7575490; http://dx.doi.org/10.1002/bies.950170605
   PubMed Web of Science ®Google Scholar
• Racioppi L. CaMKK2: a novel target for shaping the androgen-regulated tumor ecosystem. Trends Mol Med 2013; 19:83-8; PMID:23332598; http://dx.doi.org/10.1016/j.molmed.2012.12.004
   PubMed Web of Science ®Google Scholar
• Soderling TR. The Ca-calmodulin-dependent protein kinase cascade. Trends Biochem Sci 1999; 24:232-6; PMID:10366852; http://dx.doi.org/10.1016/S0968-0004(99)01383-3
   PubMed Web of Science ®Google Scholar
• Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 2012; 13:251-62; PMID:22436748; http://dx.doi.org/10.1038/nrm3311
   PubMed Web of Science ®Google Scholar
• Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 2005; 280:29060-6; PMID:15980064; http://dx.doi.org/10.1074/jbc.M503824200
   PubMed Web of Science ®Google Scholar
• Karacosta LG, Foster BA, Azabdaftari G, Feliciano DM, Edelman AM. A regulatory feedback loop between Ca2+/Calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression. J Biol Chem 2012; 287:24832-43; PMID:22654108; http://dx.doi.org/10.1074/jbc.M112.370783
   PubMed Web of Science ®Google Scholar
• Massie CE, Lynch A, Ramos-Montoya A, Boren J, Stark R, Fazli L, Warren A, Scott H, Madhu B, Sharma N. The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J 2011; 30:2719-33; PMID:21602788; http://dx.doi.org/10.1038/emboj.2011.158
   PubMed Web of Science ®Google Scholar
• Huang Q, Huang Q, Chen W, Wang L, Lin W, Lin J, Lin X. Identification of transgelin as a potential novel biomarker for gastric adenocarcinoma based on proteomics technology. J Cancer Res Clin Oncol 2008; 134:1219-27; PMID:18446369; http://dx.doi.org/10.1007/s00432-008-0398-y
   PubMed Web of Science ®Google Scholar
• Ren H, Du N, Liu G, Hu H-T, Tian W, Deng Z-P, Shi J-S. Analysis of variabilities of serum proteomic spectra in patients with gastric cancer before and after operation. World J Gastroenterol 2006; 12:2789; PMID:16718772
   PubMed Web of Science ®Google Scholar
• Wang B, Li G-X, Zhang S-G, Wang Q, Wen Y-G, Tang H-M, Zhou C-Z, Xing A-Y, Fan J-W, Yan D-W. Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer. Exp Biol Med 2011; 236:1247-53; PMID:21998129; http://dx.doi.org/10.1258/ebm.2011.011124
   PubMed Web of Science ®Google Scholar
• Mihaylova MM, Shaw RJ. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol 2011; 13:1016-23; PMID:21892142; http://dx.doi.org/10.1038/ncb2329
   PubMed Web of Science ®Google Scholar
• Greer EL, Oskoui PR, Banko MR, Maniar JM, Gygi MP, Gygi SP, Brunet A. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J Biol Chem 2007; 282:30107-19; PMID:17711846; http://dx.doi.org/10.1074/jbc.M705325200
   PubMed Web of Science ®Google Scholar
• Telles E, Gurjar M, Ganti K, Gupta D, Dalal SN. Filamin A stimulates cdc25C function and promotes entry into mitosis. Cell Cycle 2011; 10:776-82; PMID:21325883; http://dx.doi.org/10.4161/cc.10.5.14954
   PubMed Web of Science ®Google Scholar
• Zhong Z, Yeow W-S, Zou C, Wassell R, Wang C, Pestell RG, Quong JN, Quong AA. Cyclin D1/cyclin-dependent kinase 4 interacts with filamin A and affects the migration and invasion potential of breast cancer cells. Cancer Res 2010; 70:2105-14; PMID:20179208; http://dx.doi.org/10.1158/0008-5472.CAN-08-1108
   PubMed Web of Science ®Google Scholar
• Wang XH, Zhang LH, Zhong XY, Xing XF, Liu YQ, Niu ZJ, Peng Y, Du H, Zhang GG, Hu Y, et al. S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer. Am J Pathol 2010; 177:586-97; PMID:20581057; http://dx.doi.org/10.2353/ajpath.2010.091217
   PubMed Web of Science ®Google Scholar
• Yong HY, Moon A. Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells. Arch Pharm Res 2007; 30:75-81; PMID:17328245; http://dx.doi.org/10.1007/BF02977781
   PubMed Web of Science ®Google Scholar
• Racioppi L, Means AR. Calcium/calmodulin-dependent protein kinase kinase 2: roles in signaling and pathophysiology. J Biol Chem 2012; 287:31658-65; PMID:22778263; http://dx.doi.org/10.1074/jbc.R112.356485
   PubMed Web of Science ®Google Scholar
• Green MF, Anderson KA, Means AR. Characterization of the CaMKKbeta-AMPK signaling complex. Cell Signal 2011; 23:2005-12; PMID:21807092; http://dx.doi.org/10.1016/j.cellsig.2011.07.014
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75; PMID:14907713
   PubMed Web of Science ®Google Scholar
• Marimuthu A, Jacob HKC, Jakharia A, Subbannayya Y, Keerthikumar S, Kashyap MK, Goel R, Balakrishnan L, Dwivedi S, Pathare S, et al. Gene expression profiling of gastric cancer. J Proteomics Bioinform 2011; 4:74-82; http://dx.doi.org/10.4172/jpb.1000170
   PubMedGoogle Scholar
• Chatterjee A, Chang X, Nagpal JK, Chang S, Upadhyay S, Califano J, Trink B, Sidransky D. Targeting human 8-oxoguanine DNA glycosylase to mitochondria protects cells from 2-methoxyestradiol-induced-mitochondria-dependent apoptosis. Oncogene 2008; 27:3710-20; PMID:18246124; http://dx.doi.org/10.1038/onc.2008.3
   PubMed Web of Science ®Google Scholar
• Chang X, Ravi R, Pham V, Bedi A, Chatterjee A, Sidransky D. Adenylate kinase 3 sensitizes cells to cigarette smoke condensate vapor induced cisplatin resistance. PLoS One 2011; 6:e20806; PMID:21698293; http://dx.doi.org/10.1371/journal.pone.0020806
   PubMedGoogle Scholar
• De Toni F, Racaud-Sultan C, Chicanne G, Mas VM, Cariven C, Mesange F, Salles JP, Demur C, Allouche M, Payrastre B, et al. A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia. Oncogene 2006; 25:3113-22; PMID:16407823; http://dx.doi.org/10.1038/sj.onc.1209346
   PubMed Web of Science ®Google Scholar
• Ebrahimnejad A, Streichert T, Nollau P, Horst AK, Wagener C, Bamberger AM, Brummer J. CEACAM1 enhances invasion and migration of melanocytic and melanoma cells. Am J Pathol 2004; 165:1781-7; PMID:15509546; http://dx.doi.org/10.1016/S0002-9440(10)63433-5
   PubMed Web of Science ®Google Scholar
• Vizcaino JA, Cote RG, Csordas A, Dianes JA, Fabregat A, Foster JM, Griss J, Alpi E, Birim M, Contell J, et al. The PRoteomics IDEntifications (PRIDE) database and associated tools: status in 2013. Nucleic Acids Res 2013; 41:D1063-9; PMID:23203882; http://dx.doi.org/10.1093/nar/gks1262
   PubMed Web of Science ®Google Scholar
• Ryu JW, Kim HJ, Lee YS, Myong NH, Hwang CH, Lee GS, Yom HC. The proteomics approach to find biomarkers in gastric cancer. J Korean Med Sci 2003; 18:505-9; PMID:12923326; http://dx.doi.org/10.3346/jkms.2003.18.4.505
   PubMed Web of Science ®Google Scholar